Core Insights - Veeva Systems has announced a collaboration with Amgen to enhance clinical trial innovation, utilizing the Veeva Clinical Platform to improve efficiencies in the clinical trial process [1][2][3] Group 1: Collaboration Details - Amgen aims to leverage advanced technology through this collaboration to enhance its end-to-end trial operations, which is expected to expedite the delivery of innovative treatments to patients [2] - The Veeva Clinical Platform will serve as the backbone for standardized and connected processes, facilitating faster delivery of life-saving drugs [3] Group 2: Veeva Clinical Platform Overview - The Veeva Clinical Platform is a comprehensive and connected solution that encompasses various clinical operations and data applications, including CTMS, EDC, clinical workbench, RTSM, eCOA, eTMF, and more [4] - This platform is designed to streamline clinical trials from initiation to completion, automating data flow and enhancing operational efficiency [4] Group 3: Company Background - Veeva Systems provides industry-specific cloud solutions for life sciences, serving over 1,500 customers, including major biopharmaceutical companies and emerging biotech firms [5] - The company is committed to innovation, product excellence, and balancing the interests of all stakeholders, including customers, employees, and shareholders [5]

Core Insights - More than 50 medtech companies, including 11 of the top 20 and seven of the top 10 clinical research organizations, have adopted Veeva Clinical Platform applications to enhance efficiency and speed in medical device and diagnostics studies [1][2] - Companies using Veeva have reported significant improvements, achieving 50% faster study build times with Veeva EDC and 80% reductions in duplicate trial documents with Veeva eTMF [2] Company Adoption and Impact - The shift towards Veeva MedTech is driven by increasing regulatory requirements and the need for modern connected applications, moving away from siloed legacy solutions [1] - Veeva's applications enable scalability while ensuring compliance with local, regional, and global regulations [2] Customer Testimonials - Alcon reported a 50% standardization in clinical data operations within one year due to collaboration with Veeva [3] - LifeNet Health emphasized the consistent and compliant data collection enabled by Veeva's solutions for various study types [3] - Smith+Nephew noted a reduction of over 90% in quality control time and significant decreases in document creation times after implementing Veeva eTMF [3] Company Overview - Veeva Systems is recognized as the global leader in cloud software for the life sciences industry, serving over 1,000 customers, including major biopharmaceutical companies and emerging biotechs [5]

Core Insights - Veeva Systems and Sarah Cannon Research Institute (SCRI) have formed a strategic collaboration to enhance the efficiency of oncology clinical trials across SCRI's 200+ research sites [1][2] - The adoption of Veeva Clinical Platform aims to unify SCRI's contract research organization (CRO) and site management organization (SMO) for improved data flow and trial processes [1][2] Company Overview - Sarah Cannon Research Institute is a leading oncology research organization with a focus on community-based clinical trials, having conducted over 850 first-in-human clinical trials and contributed to the majority of new cancer therapies approved by the FDA in the last decade [4] - Veeva Systems is recognized as the global leader in cloud software for the life sciences industry, serving over 1,000 customers, including major biopharmaceutical companies and emerging biotechs [5] Technology and Innovation - The Veeva Clinical Platform is a comprehensive solution that integrates various clinical operations and data applications, streamlining the clinical trial process from start to finish [3] - The collaboration is expected to standardize operations on a single platform, enabling SCRI to deliver faster and more cost-effective clinical trials [3]